SCHEMBL1553485

SCHEMBL1553485

CCOC(=O)c1sc(Cl)nc1C(=O)NC(C)(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.47
CYP1A2 P05177 1/20 0.47
HPGD P15428 6/20 0.44
DPP4 P27487 1/20 0.41
NPC1 O15118 5/20 0.40
SMN1; SMN2 Q16637 6/20 0.40
RAB9A P51151 5/20 0.40
HTT P42858 4/20 0.40
MAPT P10636 3/20 0.40
GAA P10253 2/20 0.40
KDM4E B2RXH2 2/20 0.40
LMNA P02545 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
DHODH Q02127 1/20 0.40
TRPM8 Q7Z2W7 1/20 0.40
HSD17B10 Q99714 2/20 0.39
MEN1 O00255 2/20 0.39
TP53 P04637 2/20 0.39
KMT2A Q03164 2/20 0.39
HSP90AA1 P07900 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9254522 0.86 NPC1 (0.51) ALDH1A1CYP1A2HPGDDPP4NPC1
SCHEMBL1554058 0.83 ALDH1A1 (0.49) ALDH1A1CYP1A2HPGDNPC1SMN1; SMN2
SCHEMBL1505552 0.82 ALDH1A1 (0.66) ALDH1A1CYP1A2HPGDNPC1RAB9A
SCHEMBL1553145 0.82 SMN1; SMN2 (0.48) ALDH1A1CYP1A2HPGDNPC1SMN1; SMN2
SCHEMBL1553279 0.81 ALDH1A1 (0.47) ALDH1A1CYP1A2HPGDNPC1SMN1; SMN2
SCHEMBL3399751 0.81 GAA (0.48) ALDH1A1CYP1A2HPGDNPC1SMN1; SMN2
SCHEMBL12708289 0.80 CHRM4 (0.40) ALDH1A1HPGDNPC1RAB9AKDM4E
SCHEMBL27768354 0.80 ALDH1A1 (0.50) ALDH1A1HPGDHTTGAAKDM4E
SCHEMBL1553063 0.80 ALDH1A1 (0.54) ALDH1A1CYP1A2HPGDNPC1SMN1; SMN2
SCHEMBL1553046 0.80 ALDH1A1 (0.54) ALDH1A1CYP1A2HPGDNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2102199-B1 ANTIBACTERIAL POLYCYCLIC UREA COMPOUNDS ASTRAZENECA AB (SE) 2011-04-27 EP disclosed
US-7674801-B2 Alkyl urea substituted pyridines ASTRAZENECA AB (SE) 2010-03-09 US disclosed
US-7674801-B2 Alkyl urea substituted pyridines ASTRAZENECA AB (SE) 2010-03-09 US disclosed
US-7674801-B2 Alkyl urea substituted pyridines ASTRAZENECA AB (SE) 2010-03-09 US disclosed
US-20080132546-A1 CHEMICAL COMPOUNDS ASTRAZENECA AB (SE) 2008-06-05 US disclosed
US-20080132546-A1 CHEMICAL COMPOUNDS ASTRAZENECA AB (SE) 2008-06-05 US disclosed
US-20080132546-A1 CHEMICAL COMPOUNDS ASTRAZENECA AB (SE) 2008-06-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080132546-A1 CHEMICAL COMPOUNDS MRPL21, NISCH, ABCB11 ALDH1A1 488/4885CYP1A2 41/4885HPGD 389/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.